These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 3309131)

  • 21. Quality of life of patients with mild hypertension treated with captopril: a randomized double-blind placebo-controlled clinical trial.
    Hu Y; Zhu J
    Chin Med J (Engl); 1999 Apr; 112(4):302-7. PubMed ID: 11593526
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Evaluation by practicing physicians of the antihypertensive efficacy of debrisoquin, methyldopa and propranolol].
    Avigdor L; Waeber B; Brunner HR
    Schweiz Med Wochenschr; 1983 Mar; 113(9):331-8. PubMed ID: 6342133
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disparate effects of initial antihypertensive therapy on well-being.
    Otten H; Schmeider R; Rüddel H
    J Hypertens Suppl; 1987 Feb; 5(1):S37-40. PubMed ID: 3553495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Applying quality of life data in practice. Considerations for antihypertensive therapy.
    Hume AL
    J Fam Pract; 1989 Apr; 28(4):403-7; discussion 407-11. PubMed ID: 2649633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indapamide in ambulant treatment of hypertension: a comparative study with alpha-methyldopa.
    Meine H
    Postgrad Med J; 1981; 57 Suppl 2():37-8. PubMed ID: 7322958
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Captopril as a replacement therapy in hypertension improving quality of life--a multicentre study.
    Rosenthal T; Algom M; Chagnac A; Grossman E; Kisch E; Leiba M; Paran E
    Postgrad Med J; 1986; 62 Suppl 1():114-5. PubMed ID: 3317335
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monotherapy and combined treatment with captopril.
    Radó J
    Acta Physiol Hung; 1988; 72 Suppl():23-35. PubMed ID: 3075400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F; Widler J
    Schweiz Med Wochenschr; 1981 Dec; 111(50):1967-8. PubMed ID: 7036334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and safety of enalapril in moderate to severe essential hypertension.
    Walker JF; Kulaga SF; Kramsch DM
    J Hypertens Suppl; 1984 Dec; 2(2):S107-11. PubMed ID: 6100871
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical effects of low-dose captopril plus a thiazide diuretic on mild to moderate essential hypertension: a multicenter double-blind comparison with propranolol. Captopril Research Group of Japan.
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S77-81. PubMed ID: 2580181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of hypertension with alpha blockade or ACE inhibition. Multicenter double-blind study of urapidil versus captopril].
    Rosenthal J; Haerlin R
    Fortschr Med; 1986 Oct; 104(40):763-6. PubMed ID: 3536700
    [No Abstract]   [Full Text] [Related]  

  • 33. Relationships of quality-of-life measures to long-term lifestyle and drug treatment in the Treatment of Mild Hypertension Study.
    Grimm RH; Grandits GA; Cutler JA; Stewart AL; McDonald RH; Svendsen K; Prineas RJ; Liebson PR
    Arch Intern Med; 1997 Mar; 157(6):638-48. PubMed ID: 9080918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality of life in patients with essential arterial hypertension. Part II: The effect of clinical factors].
    Klocek M; Kawecka-Jaszcz K
    Przegl Lek; 2003; 60(2):101-6. PubMed ID: 12939856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interpreting quality-of-life clinical trial data for use in the clinical practice of antihypertensive therapy.
    Testa MA
    J Hypertens Suppl; 1987 Feb; 5(1):S9-13. PubMed ID: 3553497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Double-blind, randomized, cross-over clinical trial of metoprolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sahai J; Wahi PL; Sharma BK; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):163-5. PubMed ID: 3549583
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of behavioral science techniques in assessing adverse effects of antihypertensive agents.
    Williams GH
    Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):61-5. PubMed ID: 3300291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sildenafil citrate for erectile dysfunction in men receiving multiple antihypertensive agents: a randomized controlled trial.
    Pickering TG; Shepherd AM; Puddey I; Glasser DB; Orazem J; Sherman N; Mancia G
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1135-42. PubMed ID: 15607620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypertension in the elderly.
    Coope J
    J Hypertens Suppl; 1987 Aug; 5(3):S69-72. PubMed ID: 3312529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.